Turning off the switch in medulloblastoma: the inhibitory acetylation of an oncogene

Cell Cycle. 2010 Jun 1;9(11):2047-8. doi: 10.4161/cc.9.11.11860. Epub 2010 Jun 1.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Cerebellar Neoplasms / drug therapy*
  • Cerebellar Neoplasms / metabolism
  • Histone Deacetylase Inhibitors / therapeutic use
  • Histone Deacetylases / chemistry
  • Histone Deacetylases / metabolism
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Medulloblastoma / drug therapy*
  • Medulloblastoma / metabolism
  • Oncogene Proteins / antagonists & inhibitors
  • Oncogene Proteins / metabolism*
  • Trans-Activators / antagonists & inhibitors
  • Trans-Activators / metabolism*
  • Vorinostat
  • Zinc Finger Protein GLI1

Substances

  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Oncogene Proteins
  • Trans-Activators
  • Zinc Finger Protein GLI1
  • Vorinostat
  • Histone Deacetylases